Related Experiment Video

Updated: May 14, 2026

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery
09:47

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery

Published on: June 2, 2022

Anesthetic considerations in pediatric mastocytosis: a review

Norma J Klein1, Shad Misseldine

  • 1University of California, Davis, Sacramento, CA 95817, USA. incline@comcast.net

Journal of Anesthesia
|February 15, 2013
PubMed

Insights

Children with mastocytosis rarely experience severe anesthesia side effects, even with common anesthetic drugs. This review summarizes anesthetic options and safety for pediatric mastocytosis patients.

Area of Science:

  • Pediatric Anesthesiology
  • Hematology
  • Rare Diseases

Background:

  • Mastocytosis is a rare disease impacting pediatric patients requiring anesthesia.
  • Anesthetic medications can trigger mast cell activation, causing parental anxiety.
  • Current diagnostic tests do not reliably predict perioperative mast cell degranulation.

Purpose of the Study:

  • To review anesthetic management for pediatric mastocytosis.
  • To summarize reported side effects and prophylaxis strategies.
  • To provide guidance for anesthesiologists encountering these patients.

Main Methods:

  • Systematic review of pediatric literature on anesthesia and mastocytosis.
  • Analysis of case reports and expert opinions on anesthetic drug use.
  • Compilation of data on perioperative outcomes and adverse events.

Main Results:

  • Children with skin-limited mastocytosis generally tolerate anesthesia well.
  • No fatalities have been reported in pediatric mastocytosis patients undergoing anesthesia.
  • Preoperative prophylaxis is typically guided by expert consensus and case data.

Conclusions:

  • Anesthesia is generally safe for pediatric mastocytosis patients, particularly those with skin-limited disease.
  • Careful consideration of anesthetic agents and potential triggers is essential.
  • Further research is needed to establish evidence-based prophylaxis guidelines.

More Related Videos

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice09:07

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

Published on: May 27, 2015

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...